Safety and Effectiveness of Intermittent Hypoxia Treatment in Parkinson's Disease Trial Phase 1 Completed Aug. 10, 2025
Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease Trial N/A Not yet recruiting Aug. 10, 2025
A Study Comparing Propranolol and Amantadine for Reducing Tremors in People With Parkinson's Disease Trial N/A Completed Aug. 7, 2025
The Effects of fNIRS-based Neurofeedback Training on Balance and Gait in Parkinson's Disease Trial N/A Recruiting Aug. 6, 2025
Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease Trial N/A Recruiting Aug. 6, 2025
Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy Trial Phase 2 Terminated Aug. 5, 2025
Quantitation of Glymphatic Functioning in Sleep and Meditative States Trial N/A Completed Aug. 5, 2025
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy Trial Phase 2 Terminated Aug. 5, 2025
Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy Trial Phase 2 Active, not recruiting Aug. 4, 2025
Pilot Trial Evaluating Patient Experience With the MemorEM for Patients With Neurological Diseases Trial N/A Enrolling by invitation Aug. 4, 2025
Study on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease Trial N/A Recruiting Aug. 4, 2025
Evaluation of GM101 Injection in Patients With Parkinson's Disease Trial Early Phase 1 Recruiting Aug. 2, 2025
Gait and Balance Impairment in Rare and Very Rare Neurological Diseases Trial N/A Recruiting Aug. 2, 2025
EMPOWER PD - Feasibility of an Interdisciplinary Clinic for People With Parkinson's Disease Trial N/A Completed July 31, 2025